Spiriva Respimat

Spiriva Respimat

tiotropium bromide


Boehringer Ingelheim


Concise Prescribing Info
Tiotropium Br monohydrate
Maintenance bronchodilator treatment for symptomatic relief of COPD. Add-on maintenance bronchodilator treatment in patients ≥6 yr w/ severe asthma who experienced ≥1 severe exacerbations.
Dosage/Direction for Use
Hypersensitivity to tiotropium Br, atropine & its derivatives eg, ipratropium or oxitropium.
Special Precautions
Hypersensitivity. Not to be used for initial treatment of acute bronchospasm or acute symptomatic relief & 1st-line treatment for asthma. Narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction; inhalation-induced bronchospasm. Dry mouth. Avoid contact w/ eyes. May affect ability to drive & use machines. Moderate to severe renal impairment (CrCl ≤50 mL/min). Avoid use during pregnancy. Not recommended during lactation. Not recommended in childn & adolescent <18 yr.
Adverse Reactions
Dehydration; dizziness, insomnia; glaucoma, increased IOP, blurred vision; atrial fibrillation, palpitations, supraventricular tachycardia, tachycardia; cough, epistaxis, pharyngitis, dysphonia, bronchospasm, laryngitis, sinusitis; mild dry mouth, constipation, oropharyngaeal candidiasis, dysphagia, GERD, gingivitis, glossitis, stomatitis, intestinal obstruction eg, ileus paralytic; rash, pruritus, angioneurotic oedema, urticaria, skin infection & ulcer, dry skin, hypersensitivity eg, immediate reactions; joint swelling; urinary retention, dysuria, UTI.
Drug Interactions
Not recommended w/ anticholinergic agents.
ATC Classification
R03BB04 - tiotropium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.
Spiriva Respimat inhalation soln 2.5 mcg/puff
60 puff x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in